...
首页> 外文期刊>Endocrinology >MAPK Erk5 in Leptin Receptor-Expressing Neurons Controls Body Weight and Systemic Energy Homeostasis in Female Mice
【24h】

MAPK Erk5 in Leptin Receptor-Expressing Neurons Controls Body Weight and Systemic Energy Homeostasis in Female Mice

机译:MAPK ERK5在瘦素受体的神经元中的雌性小鼠控制体重和系统能量稳态

获取原文
获取原文并翻译 | 示例

摘要

Extracellular signal-regulated kinase 5 (Erk5), a member of the MAPK family, is specifically phosphorylated and activated by MAPK/Erk kinase-5. Although it has been implicated in odor discrimination and long-term memory via its expression in the central nervous system, little is known regarding the physiological importance of neuronal Erk5 in body weight and energy homeostasis. In the current study, systemic insulin injection significantly induced phosphorylation of Erk5 in the hypothalamus. Moreover, Erk5 deficiency in leptin receptor (LepR)-expressing neurons led to an obesity phenotype, with increased white adipose tissue mass due to increased adipocyte size, only in female mice fed a normal chow diet. Furthermore, ErkS deficiency in LepR-expressing neurons showed impaired glucose tolerance along with decreased physical activity, food intake, and energy expenditure. These results suggest that ErkS controls body weight and systemic energy homeostasis probably via its expression in hypothalamic neurons in female mice, thereby providing a target for metabolic diseases such as obesity and type 2 diabetes mellitus.
机译:细胞外信号调节激酶5(ERK5)是MAPK系列的成员,由MAPK / ERK激酶-5特别磷酸化和激活。虽然它通过其在中枢神经系统中的表达涉及气味鉴别和长期记忆,但关于身体重量和能量稳态的神经元ERK5的生理重要性毫无少。在目前的研究中,全身性胰岛素注射液显着诱导丘脑中ERK5的磷酸化。此外,瘦素受体(LEPR)中的ERK5缺乏 - 表达神经元导致肥胖表型,由于脂肪细胞尺寸增加,由于脂肪细胞尺寸增加,脂肪组织质量增加,仅在喂养正常味道饮食的雌性小鼠中。此外,LEPR表达神经元的ERKS缺乏症表现出葡萄糖耐量损害,以及体育活动,食物摄入量和能耗降低。这些结果表明,Erks可能通过其在雌性小鼠中的下丘脑神经元中的表达来控制体重和系统能量稳态,从而为代谢疾病如肥胖和2型糖尿病提供代谢疾病的靶标。

著录项

  • 来源
    《Endocrinology 》 |2019年第12期| 共12页
  • 作者单位

    Kanazawa Univ Div Pharmaceut Sci Mol Pharmacol Lab Grad Sch Kanazawa Ishikawa 9201192 Japan;

    Kanazawa Univ Div Pharmaceut Sci Mol Pharmacol Lab Grad Sch Kanazawa Ishikawa 9201192 Japan;

    Kanazawa Univ Inst Frontier Sci Initiat Metab &

    Nutr Res Unit Kanazawa Ishikawa 9201192 Japan;

    Kanazawa Univ Grad Sch Med Sci Dept Physiol &

    Metab Kanazawa Ishikawa 9201192 Japan;

    Kanazawa Univ Div Pharmaceut Sci Mol Pharmacol Lab Grad Sch Kanazawa Ishikawa 9201192 Japan;

    Kanazawa Univ Div Pharmaceut Sci Mol Pharmacol Lab Grad Sch Kanazawa Ishikawa 9201192 Japan;

    Kanazawa Univ Div Pharmaceut Sci Mol Pharmacol Lab Grad Sch Kanazawa Ishikawa 9201192 Japan;

    Kanazawa Univ Div Pharmaceut Sci Mol Pharmacol Lab Grad Sch Kanazawa Ishikawa 9201192 Japan;

    Kanazawa Univ Div Pharmaceut Sci Mol Pharmacol Lab Grad Sch Kanazawa Ishikawa 9201192 Japan;

    Kanazawa Univ Div Pharmaceut Sci Mol Pharmacol Lab Grad Sch Kanazawa Ishikawa 9201192 Japan;

    Kanazawa Univ Div Pharmaceut Sci Mol Pharmacol Lab Grad Sch Kanazawa Ishikawa 9201192 Japan;

    Kanazawa Univ Div Pharmaceut Sci Mol Pharmacol Lab Grad Sch Kanazawa Ishikawa 9201192 Japan;

    Nagoya City Univ Dept Gastroenterol &

    Metab Grad Sch Med Sci Nagoya Aichi 4678601 Japan;

    Kanazawa Univ Inst Frontier Sci Initiat Metab &

    Nutr Res Unit Kanazawa Ishikawa 9201192 Japan;

    Kanazawa Univ Div Pharmaceut Sci Mol Pharmacol Lab Grad Sch Kanazawa Ishikawa 9201192 Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内分泌腺疾病及代谢病 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号